HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fructose-1,6-diphosphate alone and in combination with cyclosporine potentiates rat cardiac allograft survival and inhibits lymphocyte proliferation and interleukin-2 expression.

AbstractBACKGROUND:
Fructose-1,6-diphosphate (FDP) reduces postischemic reperfusion injury and is used alone and in combination with cyclosporine A (CsA) as an immunosuppressant.
METHODS:
Wistar-Furth rat hearts were grafted to Lewis rats. Activated T-cell proliferation, viability, and interleukin-2 expression were determined.
RESULTS:
Mean survival in days were: saline 7.12+/-0.64, FDP 350 mg/kg perioperatively 13.5+/-1.4, FDP 350 mg/kg twice daily 11.4+/-0.75, CsA 2.5 mg/kg daily 12+/-0.81, CsA 5.0 mg/kg daily 12.4+/-0.81, CsA 2.5 mg/kg + FDP 350 mg/kg twice daily 17.6+/-0.4, and CsA 5 mg/kg + FDP 350 mg/kg twice daily 28.2+/-0.97. FDP maximally inhibits T-cell proliferation and concomitantly increases cell viability at 5,000 to 500 microg/mL, whereas CsA inhibits at 500 ng/mL. FDP completely inhibited interleukin-2 expression at 5,000 to 500 microg/mL, whereas CsA partially inhibited at 50 to 500 ng/mL.
CONCLUSION:
FDP + CsA prolongs cardiac survival and FDP inhibits T-cell proliferation.
AuthorsAngel K Markov, Thomas S Rayburn, David S Talton, Donald E Netherland, Charles Moore, Bobby Heath, Hari H Cohly
JournalTransplantation (Transplantation) Vol. 74 Issue 11 Pg. 1651-4 (Dec 15 2002) ISSN: 0041-1337 [Print] United States
PMID12490806 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cardiovascular Agents
  • Fructosediphosphates
  • Immunosuppressive Agents
  • Interleukin-2
  • Cyclosporine
  • fructose-1,6-diphosphate
Topics
  • Animals
  • Cardiovascular Agents (therapeutic use)
  • Cell Division (drug effects)
  • Cyclosporine (therapeutic use)
  • Drug Therapy, Combination
  • Fructosediphosphates (therapeutic use)
  • Graft Survival (drug effects)
  • Heart Transplantation
  • Immunosuppressive Agents (therapeutic use)
  • Interleukin-2 (antagonists & inhibitors)
  • Rats
  • Rats, Inbred Lew
  • Rats, Inbred WF
  • Rats, Sprague-Dawley
  • T-Lymphocytes (pathology)
  • Transplantation, Heterotopic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: